SFX by Ex Libris Inc.

Title:	Characterization of human vascular endothelial cadherin glycans
Source:	Glycobiology [0959-6658] Geyer, H yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Labelle, M. "Vascular endothelial (VE-) cadherin is expressed in breast cancer cells and promotes tumor progression." Pathology, research and practice 203.5 (2007): 277-277.
description	2.	Brasch, J. "Structure and Binding Mechanism of Vascular Endothelial Cadherin: A Divergent Classical Cadherin." Journal of Molecular Biology 408.1 (2011): 57-73.
description	3.	Tauber, R. "H (0) blood group determinant is present on soluble human L-selectin expressed in BHK-cells." FEBS letters 450.1-2 (1999): 111-116.
description	4.	Soliman, S. "Regioselective synthesis of a glycomimetic trisaccharide of Sialyl Lewis (sLex)." Carbohydrate Research 344.3 (2009): 395-399.
description	5.	Martin, T A A. "Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin." Histopathology 46.4 (2005): 422-30.
description	6.	Asnani, F. "Synthesis of Lewis X and three Lewis X trisaccharide analogues in which glucose and rhamnose replace N-acetylglucosamine and fucose, respectively." Carbohydrate Research 343.10-11 (2008): 1653-1664.
description	7.	Beyer, S. "KT5823 Differentially Modulates Sodium Iodide Symporter Expression, Activity, and Glycosylation between Thyroid and Breast Cancer Cells." The Journal of clinical endocrinology and metabolism 96.2 (2011): 555-555.
description	8.	Elledge, Heather M. "Structure of the N terminus of cadherin 23 reveals a new adhesion mechanism for a subset of cadherin superfamily members.(NEUROSCIENCE)(Author abstract)(Report)." Proceedings of the National Academy of Sciences of the United States of America (2010): 10708-.
description	9.	Subramanian, B. "The regulation of cystogenesis in a tissue engineered kidney disease system by abnormal matrix interactions." Biomaterials 33.33 (2012): 8383-94.
description	10.	Wu, Y. "Transforming binding affinities from three dimensions to two with application to cadherin clustering." Nature 475.7357 (2011): 510-513.
description	11.	Castellino, F. "Glycosylation of asparagine-28 of recombinant staphylokinase with high-mannose-type oligosaccharides results in a protein with highly attenuated plasminogen activator activity." Journal of biological chemistry 274.12 (1999): 7769-7776.
description	12.	Nelson, Elizabeth J. "VE-cadherin: at the front, center, and sides of endothelial cell organization and function." Current opinion in cell biology 22.5 (2010): 651-658.
description	13.	Eswaramoorthy, R. "DDR1 regulates the stabilization of cell surface E-cadherin and E-cadherin-mediated cell aggregation." Journal of cellular physiology 224.2 (2010): 387-397.
description	14.	Nagai, Y. "Regio- and chemoselective manipulation under mild conditions on glucosamine derivatives for oligosaccharide synthesis and its application toward N-acetyl-D-lactosamine and Lewis X trisaccharide." Tetrahedron 64.40 (2008): 9599-9606.
description	15.	Prodger, Jeremy C. "Synthesis of a novel analog of sialyl Lewis X." Tetrahedron Letters 36.13 (1995): 2339-2342.
description	16.	Jun, Ning g. "Large-scale preparation of the phytoalexin elicitor glucohexatose and its application as a green pesticide." Journal of agricultural and food chemistry 51.4 (2003): 987-991.
description	17.	Ueda, M. "Sequence control in one-step condensation polymerization." Progress in polymer science 24.5 (1999): 699-730.
description	18.	Nishida, Y. "Convenient synthetic approach towards C-3 modified methyl Î²-lactosides." Carbohydrate Research 263.2 (1994): 295-301.
description	19.	Priest, R. "Mimics of the sialyl Lewis X tetrasaccharide. Replacement of the N-acetylglucosamine sugar with simple C-2-symmetric 1,2-diols." Bioorganic & medicinal chemistry 4.6 (1996): 793-801.
description	20.	Sahni, A. "The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells." International journal of cancer 125.3 (2009): 577-84.